Pharmafile Logo
Pharmafocus logo
Advanced Search

Transplant patients to have mandatory full COVID vaccinations at London Health Sciences Centre

November 2, 2021
Manufacturing and Production

The Ontario-based London Health Sciences Centre’s transplant program is implementing a full COVID-19 vaccination requirement for future organ transplant recipients …

News

Dunad Therapeutics and Novartis enter partnership to develop protein therapies

November 2, 2021
Manufacturing and Production

Biopharmaceutical company Dunad Therapeutics (Dunad) has annouced that it has entered into a strategic collaboration with Novartis, to develop orally …

News

FDA approve Novartis’ Scemblix to treat leukaemia

November 2, 2021
Manufacturing and Production

Novartis have announced that the FDA approved Scemblix® (asciminib) for the treatment of chronic myeloid leukaemia (CML) in two distinct …

News

Skin patch COVID vaccine may prove more effective than injections

November 1, 2021
Sales and Marketing

A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership …

News

China says US COVID origins report lacks credibility

November 1, 2021
Sales and Marketing

A US intelligence report saying it was plausible that COVID-19 originated in a Wuhan laboratory has been deemed unscientific and …

News

FDA issue Pfizer vaccine emergency clearance for children, and delay Moderna

November 1, 2021
Sales and Marketing

The FDA has informed Moderna that it needs more time to review the company’s COVID vaccine in children aged 12 …

News

Study reveals high efficacy of Sputnik V in protecting aged 60+ against COVID

November 1, 2021
Sales and Marketing

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) has announced the results of a real world study by …

News

Gilead collaborate with Merck for first-line triple negative breast cancer trial

October 29, 2021
Medical Communications

Gilead Sciences announced that it has entered into a clinical trial collaboration and supply agreement with MSD (known as Merck …

News

Fluvoxamine effective in reducing hospitalisation in COVID-19 patients

October 29, 2021
Medical Communications

A Brazilian study has assessed the effect of early treatment with fluvoxamine on the risk of emergency care and hospitalisation …

News

FDA approve Susvimo for wet age-related macular degeneration

October 29, 2021
Medical Communications

Genentech have announced that Susvimo, previously known as the port delivery system, is the fist wet age-related macular degeneration (AMD) …

News

XBiotech to launch novel therapy for stroke patients in US

October 29, 2021
Medical Communications

Clinical stage biopharmaceutical company, XBiotech, plans to test its new True Humanâ„¢ antibody therapy for reducing brain injury after stroke, …

News

Angel Pharmaceuticals receives IND approval for Phase 1/1b Inhibitor in China

October 28, 2021
Business Services

Angel Pharmaceuticals has received approval for their IND application, from the Center for Drug Evaluation (CDE) of the China National …

News
credit_-_crevis_shutterstock_340710245_720

Serial radiation therapy safe as alternative treatment for kidney cancer

October 28, 2021
Business Services

The University of Texas MD Anderson Cancer Center has reported that Serial radiation therapy as monotherapy is a safe and …

News

First long-acting HIV-treatment to be distributed in European countries

October 28, 2021
Business Services

ViiV Healthcare, the global specialist HIV company, have presented positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine), the first …

News

FDA approves Phase II clinical trial of combination treatment for COVID-19

October 28, 2021
Business Services

The FDA has approved Vitti Labs’ Investigational New Drug (IND) application to conduct Phase II Clinical Trials using a combination …

News

Plan C COVID strategy being discussed by government

October 27, 2021
Research and Development

An advisor to the Department of Health told MPs a ‘Plan C’ has been mentioned in Government discussions, should the …

News

Quell Therapeutics receives CTA approval to begin first clinical trial with a multi-modular engineered treg cell company

October 27, 2021
Research and Development

The MHRA has approved Quell Therapeutics’ first clinical trial for its lead cell therapy candidate QEL-001. This approval paves the …

News

Study finds link between COVID-19 infection and neurological complications

October 27, 2021
Research and Development

A study conducted by Nature Medicine has revealed an increased risk of Guillain-Barre Syndrome (GBS) and Bell’s palsy following a …

News

FDA and EMA approve Novartis’ treatment for follicular lymphoma patients

October 27, 2021
Research and Development

The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …

News

NIHR funds COVID-19 antiviral trial

October 26, 2021
Manufacturing and Production

The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026